T 2444/18 of 20.09.2022

European Case Law Identifier: ECLI:EP:BA:2022:T244418.20220920
Date of decision: 20 September 2022
Case number: T 2444/18
Petition for review of: -
Application number: 12852587.0
IPC class: A61K 31/198 A61P 43/00 A61K 45/00 A61P 35/00 A61K 31/44
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: AGENT FOR REDUCING ADVERSE SIDE EFFECTS OF KINASE INHIBITOR
Applicant name: EA Pharma Co., Ltd.
Yamaguchi University
Opponent name: N.V. Nutricia
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 56 European Patent Convention Art 83 European Patent Convention R 80Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
Keywords: Sufficiency of disclosure - after amendment
Inventive step - (yes)
Catchword: -
Cited cases: T 0021/16 T 0946/16
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent as amended in the following version:

- Claims: claims 1 to 13 according to auxiliary request 32 filed with the letter dated 7 September 2022

- Description: pages 2 to 9 filed during the oral proceedings of 11 June 2018

- Drawings: sheets 1/2 to 2/2 of the patent specification